Purchase Order 75N90021P00727

The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed-price Blanket Purchase Agreement (BPA) call order to Baxalta US Inc., a foreign-owned, for-profit pharmaceutical company, to provide the GLASSIA medicine. The contract, valued at $118,800.00, was awarded under the GSA Pharmaceuticals and Drugs schedule contract and does not have a set-aside designation. Baxalta is a provider of specialty pharmaceuticals, including products for the treatment of bleeding...

This is a firm fixed-price purchase order (SPE2DP20P1175) awarded by the Defense Logistics Agency (DLA) to Baxalta US Inc., a foreign-owned pharmaceutical company, for the supply of 8507661500 - ALBUMIN HUMAN. The contract has an ultimate completion date of October 19, 2020 and a ceiling value of $3,520.65. Baxalta is a provider of specialty pharmaceuticals, including products for the treatment of bleeding disorders, immunodeficiencies, and other rare chronic conditions. The company has...

This is a federal contract award to Baxalta US Inc., a foreign-owned, for-profit pharmaceutical company, by the U.S. Department of Veterans Affairs' Veterans Integrated Service Network 21. The contract is for the delivery of Globulin, Immune (IV) 30GM/Vial, a specialty pharmaceutical product, under the General Services Administration (GSA) Pharmaceuticals and Drugs schedule contract. The contract has a ceiling value of $79,748.10 and an ultimate completion date of September 30, 2019. No...

<p>This is a firm fixed-price Blanket Purchase Agreement (BPA) call for PROLASTIN C, awarded by the U.S. Department of Veterans Affairs (VA) to Talecris Biotherapeutics Incorporated, with a ceiling value of $109,345.92. The contract has an ultimate completion date of September 30, 2016. This award is not associated with a set-aside program. The place of performance is Springfield, MI 49037.</p>

This is a delivery order contract awarded by the Veterans Integrated Service Network 20 (VISN 20), a division of the U.S. Department of Veterans Affairs (VA), to Grifols USA LLC. The $111,000.00 firm fixed-price contract is for the supply of PROLASTIN-C LIQUID, a plasma-derived alpha1-proteinase inhibitor used to treat alpha1-antitrypsin deficiency. The contract is part of Grifols' $1.38 billion Federal Supply Schedule contract with the VA for Pharmaceuticals and Drugs. The contract has a...

This is a firm fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to Baxalta US Inc., a foreign-owned, for-profit pharmaceutical company, under the GSA Pharmaceuticals and Drugs schedule contract. The contract is for the provision of BLOOD PRODUCT with a ceiling value of $113,835.30 and a period of performance ending on December 15, 2016. The contract was awarded on December 15, 2016 and was not set aside for any specific business type. Baxalta US Inc....

This is a $75,310.20 firm fixed-price delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to Baxalta US Inc., a foreign-owned for-profit pharmaceutical company, for the supply of blood products. The contract is issued against Baxalta's General Services Administration (GSA) Federal Supply Schedule 61-IB for Pharmaceuticals and Drugs. No set-aside designation was used for this award. Baxalta has previously received other prime contract awards from the VA, Department...

CSL Behring L.L.C. was awarded a firm fixed-price blanket purchase agreement (BPA) call contract valued at one hundred thirty-six thousand four hundred forty-one dollars and eighty-eight cents ($136,441.88) by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8. The contract calls for delivery of the pharmaceutical Privigen under the Pharmaceuticals and Drugs Federal Supply Schedule master contract. Performance will occur in Gainesville,...

This is a firm fixed-price BPA call order issued by the U.S. Department of Veterans Affairs (VA) to CSL Behring L.L.C., a large foreign-owned for-profit biotherapeutics company, for the provision of GLOBULINE, IMMUNE PRIVIGEN 5GM, a plasma-derived pharmaceutical product, valued at $79,338.60. The order was placed against CSL Behring's existing Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB), which has a total ceiling value of $201,482,280 and is valid through...

This Blanket Purchase Agreement (BPA) call was awarded under the Department of Veterans Affairs' (VA) Veterans Integrated Service Network 8's (VISN 8) master GSA Schedule contract for pharmaceuticals and drugs. CSL Behring L.L.C. will deliver $25,227.62 worth of Privigen 675A00060, a human plasma-derived intravenous immunoglobulin product, on a firm fixed price basis to locations in King of Prussia, Pennsylvania. No set-aside designation was applied to this BPA call issued under the VA's...